Advertisement
Screener

THE PENNANT GROUP, INC. (PNTG) Overview

THE PENNANT GROUP, INC. (PNTG) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.25; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.24; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.17; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.20; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$22.56$25.86$29.63$33.96$38.92$44.602025-11-062026-11-06$8.67$12.03$16.70$23.17$32.15$44.602021-11-082026-11-06$8.67$13.16$19.97$30.31$46.00$69.802019-10-012026-11-06$8.67$13.16$19.97$30.31$46.00$69.802019-10-012026-11-06$8.67$13.16$19.97$30.31$46.00$69.802019-10-012026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$36.36
Previous close
$40.50
Change
-$4.14
Change (%)
-10.22%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

PNTG
+43.87%
S&P 500
(m)

1 year

PNTG
+60.84%
S&P 500
(m)

3 years

PNTG
+263.88%
S&P 500
(m)

5 years

PNTG
+36.64%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.25

0.090.170.260.350.4331 Mar 2025: estimate (m); actual 0.2231 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.2030 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.1730 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.2431 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.2530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.25(m)(m)
1 Jan 202631 Mar 2026(m)0.24(m)(m)
1 Jul 202530 Sept 2025(m)0.17(m)(m)
1 Apr 202530 Jun 2025(m)0.20(m)(m)
1 Jan 202531 Mar 2025(m)0.22(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.84

0.010.260.520.771.0231 Dec 2021: estimate (m); actual 0.0931 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.2231 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.4431 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.7031 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.8431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.84(m)(m)
1 Jan 202431 Dec 2024(m)0.70(m)(m)
1 Jan 202331 Dec 2023(m)0.44(m)(m)
1 Jan 202231 Dec 2022(m)0.22(m)(m)
1 Jan 202131 Dec 2021(m)0.09(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 297.98M ■ Earnings 9.08M — Profit margin 3.05%

-35.76M1.7%87.41M2.5%210.58M3.3%333.74M4.0%30 Sept 2025: revenue 229.04M; earnings 6.08M; profit margin 2.66%30 Sept 202531 Dec 2025: revenue 289.32M*; earnings 8.64M*; profit margin 2.99%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 285.36M; earnings 8.52M; profit margin 2.99%31 Mar 202630 Jun 2026: revenue 297.98M; earnings 9.08M; profit margin 3.05%30 Jun 2026

31 Dec 2025 ■ Revenue 947.71M ■ Earnings 29.58M — Profit margin 3.12%

-113.72M0.4%277.99M1.7%669.71M3.0%1061.43M4.2%31 Dec 2022: revenue 473.24M; earnings 6.64M; profit margin 1.40%31 Dec 202231 Dec 2023: revenue 544.89M; earnings 13.38M; profit margin 2.46%31 Dec 202331 Dec 2024: revenue 695.24M; earnings 22.56M; profit margin 3.24%31 Dec 202431 Dec 2025: revenue 947.71M; earnings 29.58M; profit margin 3.12%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$36.36(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$36.36High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning PNTG

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$32.32M
Profit margin
2.93%
Return on assets · 12 month
3.61%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
391.50K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
2.77%*
Total return · month
9.22%*
Total return · quarter
11.45%*
Total return · half year
35.72%*
Total return · year to date
43.87%*
Total return · 1 year
60.84%*
Total return · 3 years
263.88%*
Total return · 5 years
36.64%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$1.10B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

THE PENNANT GROUP, INC. Overview

View more →

(m)

(m)

SEC CIK
1766400
Industry (SIC)
8000 Services-Health Services
Country of operation
United States
Business address
1675 E. RIVERSIDE DRIVE, EAGLE, Idaho, 83616, United States
Fiscal year end
1231
Phone
(208) 401-1400

Similar stocks

Stock NameCountryMarket CapPE Ratio
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86